China Pushes for Cheaper Health Insurance Products to Battle Virus

2 Min Read
Medical workers in protective suits attend to patients at the Wuhan International Conference and Exhibition Center, which has been converted into a makeshift hospital to receive patients with mild symptoms caused by the novel coronavirus, in Wuhan, Hubei province, China February 5, 2020. Picture taken February 5, 2020. China Daily via REUTERS ATTENTION EDITORS - THIS IMAGE WAS PROVIDED BY A THIRD PARTY. CHINA OUT.

China is nudging insurers to work on cheaper medical cover linked to the coronavirus and is assuring them of fast-track approval for these new products.

The move will mark a shift in the Chinese insurance market where the bulk of existing products are essentially investment schemes and pure healthcare coverage accounts for only about a fifth of the total life insurance premium.

According to their websites, China Life (601628.SS), China Pacific Insurance (2601.HK), Ping An Insurance Group (601318.SS) and Zhong An Online P&C Insurance Co (6060.HK), among others, have included coverage for the virus in their existing medical insurance products.

At least half a dozen more are in the process of requesting approval for products with coronavirus coverage in the coming weeks, said the people, declining to be named as they were not authorised to speak to the media.

The scramble comes as the Chinese province of Hubei, at the epicentre of the outbreak, reported a record surge in the death toll on Thursday.

READ ALSO:South Korea to End Outbreak of New Strain of COVID-19 – President Moon

However, the global health experts warned that the epidemic could get far worse before it is brought under control.

China’s Banking and Insurance Regulator (CBIRC) have adjusted actuary rules for healthcare, accident and life insurance as well annuity insurance, which will help lower premiums for such insurance by 3% to 5%.

The sources said the lower premiums and push for cheaper, basic medical cover, were largely prompted by the need to deal with treatment for those who may get infected by the coronavirus.

CBIRC did not respond to Reuters request for comment.

Share this Article
Leave a comment

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.